Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Clinical trial NCT00530816 · COMPLETED

Trial details

NCT number: NCT00530816
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2007-09-01
Primary completion: 2013-01-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.